Description

▪ Introduction

Turinex 10 contains pharmaceutical-grade Turinabol (Chlorodehydromethyltestosterone), an oral anabolic androgenic steroid used extensively in laboratory research to study anabolic pathways and androgen receptor interactions. Manufactured by Novotex Pharma, this product is provided as blister-packed tablets, ensuring precise dosing for analytical and experimental applications.

▪ Product Details

• Active Ingredient: Turinabol (Chlorodehydromethyltestosterone)

• Dosage Strength: 10 mg per tablet

• Form: Oral tablets

• Brand: Novotex Pharma

• Package Size: 100 tablets (boxed, blister-packed)

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Turinabol exhibits high oral bioavailability due to its 4-chloro substitution which prevents rapid hepatic metabolism. It has a half-life of approximately 16 hours in simulated in-vitro studies. The compound undergoes hepatic metabolism primarily via hydroxylation and glucuronidation, making it relevant for studies involving steroid metabolism and receptor binding kinetics.

▪ Usage Recommendations

Typical laboratory usage simulates administration of 10–40 mg daily depending on the test model and duration. Tablets should be stored in original blister packaging to preserve stability. Handle in compliance with laboratory safety protocols.

▪ Disclaimer

This product is intended strictly for laboratory research and analytical use. Not approved for human consumption or medical treatment. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health conditions. Must be handled per applicable safety and regulatory guidelines.